Veradigm Inc (MDRX)

Veradigm Inc. is a healthcare technology company whose common stock is listed on OTC Markets under the symbol MDRX. The company provides information technology solutions for healthcare providers, payers, and biopharma customers in the United States and internationally. Its portfolio includes practice management software, AI-based patient scheduling, electronic statements and payments, clearinghouse capabilities, revenue cycle and coding services, and electronic health records tools such as ePrescribe with EPCS, Veradigm EHR, and Practice Fusion EHR. Veradigm also serves network partners and life sciences clients with API connectivity, diagnostic ordering and result networks, patient engagement tools, risk adjustment and quality analytics, data exchange and coding solutions, clinical data registries, provider engagement services, care gap alerting, and real-world data and evidence analytics. The company was formerly known as Allscripts Healthcare Solutions, Inc., adopted the Veradigm name in January 2023, and is headquartered in Chicago, Illinois.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Market Cap
OTC-MDRX
Not available
$8
61.6% Upside
Bargain
Good
0.0%
November 6, 2026
842.9 M
Valuation • Fair Value

Veradigm Inc (OTC-MDRX) Fair Value by Valuation Model

Review the valuation references currently available for Veradigm Inc (OTC-MDRX).

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

$8

Analysts imply upside of 61.6%.

How to read these valuation models

Use the available valuation reference for Veradigm Inc (OTC-MDRX) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Veradigm Inc (OTC-MDRX)

Review the profitability and growth indicators currently supported by the latest data.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Veradigm Inc (OTC-MDRX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Veradigm Inc (OTC-MDRX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Veradigm Inc (OTC-MDRX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Veradigm Inc (OTC-MDRX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 6, 2026

Days to Earnings

13

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Veradigm Inc (OTC-MDRX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Veradigm Inc (OTC-MDRX) Stock Forecast & Technical Outlook

Review Veradigm Inc (OTC-MDRX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Buy

The 15-minute technical read for Veradigm Inc (OTC-MDRX) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for Veradigm Inc (OTC-MDRX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Veradigm Inc (OTC-MDRX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Neutral

The weekly technical read for Veradigm Inc (OTC-MDRX) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Sell

The monthly technical read for Veradigm Inc (OTC-MDRX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Veradigm Inc (OTC-MDRX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Veradigm Inc (OTC-MDRX) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Veradigm Inc (OTC-MDRX) Stock FAQ

Data-supported answers about Veradigm Inc (OTC-MDRX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Analyst Target
$8
Implied upside 61.6%
Financial Health
Good
Current financial-health read

A reliable fair value estimate is not currently available for Veradigm Inc (OTC-MDRX). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The available analyst price target for Veradigm Inc (OTC-MDRX) is $8. The analyst target implies estimated upside of 61.6%.

The current financial health read for Veradigm Inc (OTC-MDRX) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Veradigm Inc (OTC-MDRX) is November 6, 2026.

The latest available data indicates no current dividend yield for Veradigm Inc (OTC-MDRX).

The current market capitalization listed for Veradigm Inc is 842.9 M.

The ticker symbol for Veradigm Inc is OTC-MDRX, and the stock is listed on OTC Markets.

Veradigm Inc (OTC-MDRX) is listed on OTC Markets.